View in EDS

1142P Dynamics and prognostic impact of HER3 expression in advanced ovarian cancer treated with neoadjuvant chemotherapy: Results from the CHIVA GINECO study.

Saved in:
Bibliographic Details
Title: 1142P Dynamics and prognostic impact of HER3 expression in advanced ovarian cancer treated with neoadjuvant chemotherapy: Results from the CHIVA GINECO study.
Authors: Diaz, B.L. Alvarez1 (AUTHOR), Genestie, C.1 (AUTHOR), Blanc-Durand, F.2 (AUTHOR), Kaminsky-Forrett, M-C.3 (AUTHOR), Lacourtoisie, S. Abadie4 (AUTHOR), Lobbedez, F. Joly5 (AUTHOR), Meunier, J.6 (AUTHOR), Berton-Rigaud, D.7 (AUTHOR), Dohollou, N.8 (AUTHOR), Desauw, C.9 (AUTHOR), Quesada, S.10 (AUTHOR), Kurtz, J.E.11 (AUTHOR), Lamichhane, N. Bonichon12 (AUTHOR), Follana, P.13 (AUTHOR), Lotz, J-P.14 (AUTHOR), Pautier, P.15 (AUTHOR), Trecourt, A.1 (AUTHOR), Ouali, K.16 (AUTHOR), Leary, A.15 (AUTHOR), Yaniz, E.17 (AUTHOR)
Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS757-S757. 1p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2025.08.1778